BON · Bon Natural Life Ltd · Financials
Market Cap
$11.19M
Shares
10.17M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$18.67M
-21.7%
FY2025
Net Income
-$1.99M
-601%
FY2025
Gross Margin
20.77%
-9pp
FY2025
Operating Margin
-8.69%
-16.6pp
FY2025
Diluted EPS
-$0.72
-117.4%
FY2025
Operating Cash Flow
$141.12K
+101.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| $18.67M | $23.84M | $29.52M | $29.91M | $25.49M | $18.22M | $16.4M | |
| — | — | — | $425 | $15.71K | — | — | |
| $14.79M | $16.73M | $20.68M | $20.48M | $18.38M | $13.02M | $11.11M | |
| $3.88M | $7.11M | $8.84M | $9.42M | $7.11M | $5.2M | $5.28M | |
| 20.77% | 29.82% | 29.94% | 31.51% | 27.9% | 28.55% | 32.22% | |
| $754.19K | $1.62M | $298.47K | $424.56K | $249.05K | $205.36K | $522.87K | |
| $4.31M | $3.35M | $2.31M | $2.18M | $1.32M | $1.37M | $1.31M | |
| $38.75K | $24.11K | $9010 | $7610 | $8641 | $4070 | — | |
| $1.09M | $1.11M | $954.52K | $218.53K | $228.55K | $230.6K | $226.63K | |
| $5.5M | $5.24M | $2.9M | $2.82M | $1.71M | $1.73M | $2.11M | |
| -$1.62M | $1.87M | $5.94M | $6.6M | $5.4M | $3.47M | $3.18M | |
| -8.69% | 7.86% | 20.11% | 22.07% | 21.18% | 19.03% | 19.37% | |
| -$535.58K | $2.98M | $6.89M | $6.82M | $5.63M | $3.7M | $3.4M | |
| $366.18K | $303.33K | $238.22K | $446.88K | $417.27K | $329.1K | $333.19K | |
| $867 | $393 | $9414 | $1378 | $3207 | $714 | $2271 | |
| -$86.8K | -$1.16M | -$363.59K | $969.29K | $29.76K | $186.41K | -$185.34K | |
| -$1.71M | $715.94K | $5.57M | $7.57M | $5.43M | $3.65M | $2.99M | |
| $339.41K | $351.18K | $1M | $1.27M | $820.93K | $556.26K | $427.19K | |
| -$1.99M | $398.17K | $4.6M | $6.24M | $4.59M | $3.03M | $2.57M | |
| -10.68% | 1.67% | 15.57% | 20.86% | 18.01% | 16.61% | 15.7% | |
| -$54.66K | -$52.92K | -$43.3K | $4936 | $18.65K | $71.64K | -$11.17K | |
| -$2.29M | $1.5M | $3.55M | $3.39M | $5.22M | $3.47M | $2.29M | |
| USD/shares | -$0.72 | $4.17 | $125.72 | $186.75 | $17.25 | $14.50 | $125.00 |
| USD/shares | -$0.72 | $4.14 | $124.92 | $185.75 | $17.00 | $14.50 | $125.00 |
| shares | 2.76M | 95.51K | 36.56K | 33.44K | 264.63K | 208.43K | 20.67K |
| shares | 2.76M | 96.11K | 36.79K | 33.58K | 268.25K | 208.43K | 20.67K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Specialty Chemicals median 1.91×
EV/EBIT
—
Specialty Chemicals median 24.07×
P/E (TTM)
—
Specialty Chemicals median 27.49×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| China | $23,542,870 | $28,971,115 | $28,756,333 | $23,704,259 | — | — |
| Overseas | $301,686 | $551,238 | $1,152,228 | $1,790,305 | $2,758,158 | — |
| Overseas | — | — | — | $1,790,305 | — | $5,203,694 |
| PRC | — | — | — | $23,704,259 | — | $11,192,324 |
| PRC | — | — | — | $23,704,259 | $15,461,801 | — |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Fragrance Compounds | $8,081,897 | $4,944,475 | $14,315,810 | $13,710,556 | — | $7,879,300 | — |
| Bioactive Food Ingredients | $7,261,923 | $12,159,451 | $6,502,075 | $9,052,297 | — | $6,453,563 | — |
| Health Supplements Solid Drinks | $3,326,864 | $6,740,630 | $8,704,468 | $7,145,708 | — | $3,887,096 | — |
| Bioactive Food Ingredients | — | — | — | — | $6,094,553 | — | $5,315,254 |
| Fragrance Compounds | — | — | — | — | $12,744,029 | — | $6,738,274 |
| Health Supplements Solid Drinks | — | — | — | — | $6,655,982 | — | $4,342,490 |